Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

NCT: NCT03297125 · ACTIVE_NOT_RECRUITING

NCT IDNCT03297125
StatusACTIVE_NOT_RECRUITING
Start Date2017-12-01
Completion2026-12-31
SponsorMedical College of Wisconsin (OTHER)
First posted
Last updated

Brief Summary

The purpose of this prospective, nonrandomized controlled phase IV study is to compare standard and advanced MRI for their ability to predict response to Optune therapy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑